MAPT and Alzheimer disease: For instance, a survey by Ke et al. provided evidence for the involvement of NEAT1 in the accelerated progression of Alzheimer's disease, and it was found that downregulation increased the generation of P-tau, enhancing Aβ levels and generating neuronal damage.